Information
-
Trademark
-
99025787
-
International Classifications
-
Filing Date
January 31, 2025
7 days ago
-
Transaction Date
February 01, 2025
6 days ago
-
Status Date
January 31, 2025
7 days ago
-
Status Code
630
-
-
Attorney Docket Number
NEUB 2504447
Attorney Name
Allison Strickland Ricketts
-
Owners
Mark Drawing Code
0
Mark Identification
CRENESSITY
Case File Statements
- DM0000: The mark consists of four lines with curved top and bottom edges that become progressively larger from left to right and form the overall shape of a conical seashell. The lines appear left to right in a gradient of color from purple to orange to yellow and are positioned above the word CRENESSITY.
- GS0051: Pharmaceutical preparations for the treatment of adrenal insufficiency; pharmaceutical preparations for the treatment of hormonal and genetic diseases, disorders and conditions; pharmaceutical preparations for the diagnosis, prevention and treatment of endocrine diseases and disorders; pharmaceutical preparations for the treatment of congenital adrenal hyperplasia; pharmaceuticals for the treatment of rare and orphan hormonal and genetic diseases, disorders and conditions
- CC0000: The color(s) purple, orange, and yellow is/are claimed as a feature of the mark.
- GS0441: Providing medical information; Providing medical information to patients, medical professionals, and insurance companies in the field of congenital adrenal hyperplasia and other endocrine diseases and disorders; on-line information services, namely, providing medical information to patients, medical professionals, and insurance companies in the field of congenital adrenal hyperplasia and other endocrine diseases and disorders
- GS0421: Providing medical research information; providing medical research information in the field of pharmaceuticals and clinical trials focusing on congenital adrenal hyperplasia and other endocrine diseases and disorders; Scientific research in the nature of conducting clinical trials for pharmaceutical preparations for the treatment of congenital adrenal hyperplasia and other endocrine diseases and disorders, for others; conducting post-authorization pharmaceutical research for the marketing of pharmaceutical preparations and evaluating epidemiological results
Case File Event Statements
-
1/31/2025 - 7 days ago
1 - NEW APPLICATION ENTERED
Type: NWAP
-
1/31/2025 - 7 days ago
2 - APPLICATION FILING RECEIPT MAILED
Type: MAFR